Sada Mitsuru, Kimura Hirokazu, Nagasawa Norika, Akagawa Mao, Okayama Kaori, Shirai Tatsuya, Sunagawa Soyoka, Kimura Ryusuke, Saraya Takeshi, Ishii Haruyuki, Kurai Daisuke, Tsugawa Takeshi, Nishina Atsuyoshi, Tomita Haruyoshi, Okodo Mitsuaki, Hirai Shinichiro, Ryo Akihide, Ishioka Taisei, Murakami Koichi
Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki 370-0006, Gunma, Japan.
Advanced Medical Science Research Center, Gunma Paz University Research Institute, Shibukawa 377-0008, Gunma, Japan.
Microorganisms. 2022 Aug 17;10(8):1660. doi: 10.3390/microorganisms10081660.
DNA gyrase plays important roles in genome replication in various bacteria, including . The gene encodes the gyrase subunit A protein (GyrA). Mutations in GyrA are associated with resistance to quinolone-based antibiotics. We performed a detailed molecular evolutionary analyses of the gene and associated resistance to the quinolone drug, ciprofloxacin, using bioinformatics techniques. We produced an evolutionary phylogenetic tree using the Bayesian Markov Chain Monte Carlo (MCMC) method. This tree indicated that a common ancestor of the gene was present over 760 years ago, and the offspring formed multiple clusters. Quinolone drug-resistance-associated amino-acid substitutions in GyrA, including T83I and D87N, emerged after the drug was used clinically. These substitutions appeared to be positive selection sites. The molecular affinity between ciprofloxacin and the GyrA protein containing T83I and/or D87N decreased significantly compared to that between the drug and GyrA protein, with no substitutions. The rate of evolution of the gene before quinolone drugs were first used in the clinic, in 1962, was significantly lower than that after the drug was used. These results suggest that the gene evolved to permit the bacterium to overcome quinolone treatment.
DNA促旋酶在包括……在内的多种细菌的基因组复制中发挥着重要作用。该基因编码促旋酶亚基A蛋白(GyrA)。GyrA中的突变与对喹诺酮类抗生素的耐药性有关。我们使用生物信息学技术对该基因以及对喹诺酮药物环丙沙星的相关耐药性进行了详细的分子进化分析。我们使用贝叶斯马尔可夫链蒙特卡罗(MCMC)方法构建了进化系统发育树。这棵树表明该基因的一个共同祖先存在于760多年前,其后代形成了多个簇。GyrA中与喹诺酮药物耐药性相关的氨基酸替换,包括T83I和D87N,在该药物临床使用后出现。这些替换似乎是正选择位点。与环丙沙星和不含替换的GyrA蛋白之间的分子亲和力相比,环丙沙星与含有T83I和/或D87N的GyrA蛋白之间的分子亲和力显著降低。在1962年喹诺酮类药物首次临床使用之前,该基因的进化速率明显低于药物使用之后。这些结果表明该基因发生进化以使细菌能够克服喹诺酮治疗。